Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
NDC Package Code : 55463-0031
Start Marketing Date : 2007-02-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
58
PharmaCompass offers a list of Aprotinin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Aprotinin manufacturer or Aprotinin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Aprotinin manufacturer or Aprotinin supplier.
PharmaCompass also assists you with knowing the Aprotinin API Price utilized in the formulation of products. Aprotinin API Price is not always fixed or binding as the Aprotinin Price is obtained through a variety of data sources. The Aprotinin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Antilysin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Antilysin, including repackagers and relabelers. The FDA regulates Antilysin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Antilysin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Antilysin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Antilysin supplier is an individual or a company that provides Antilysin active pharmaceutical ingredient (API) or Antilysin finished formulations upon request. The Antilysin suppliers may include Antilysin API manufacturers, exporters, distributors and traders.
click here to find a list of Antilysin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Antilysin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Antilysin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Antilysin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Antilysin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Antilysin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Antilysin suppliers with NDC on PharmaCompass.
